IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fate Therapeutics
University of Chicago
Memorial Sloan Kettering Cancer Center
University of Southern California
Nurix Therapeutics, Inc.
AstraZeneca
University of Chicago
AIDS Malignancy Consortium
Oncology Institute of Southern Switzerland
Massachusetts General Hospital
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center